Recent Biosimilars Research for November 2024
Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change
Including: 1) By Application: Chemotherapy Induced Neutropenia; Transplantation; Others
2) By Distribution Channel: Hospital Pharmacies; Retail Pharma
Topics: Biosimilars, Hospitals & Clinics, Pharmacy & Distribution, Clinical Trial, Drug Stores, E-Commerce & Online Retailing
Regions: Global
| Biosimilars Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Topics: Biosimilars, COVID-19/Coronavirus
| Biopharmaceutical CMO Market Analysis and Forecast to 2031: By Product (Biologics, Biosimilars), Source (Mammalian, Non-mammalian), Service (Contract Manufacturing, Process Development, Packaging, Others), and Region
Topics: Biosimilars, Biologics, Biopharmaceuticals
Regions: Global
| SOUTH KOREA DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
Topics: Biosimilars, Diabetes, COVID-19/Coronavirus, Drug Discovery
Regions: South Korea
| North America Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Country and Growth Forecast, 2022 - 2028
Topics: Biosimilars, Blood Diseases, Autoimmune, Oncology/Hematology
Regions: North America
| Global Trastuzumab Biosimilar Market Research Report 2022 - Market Size, Current Insights and Development Trends
Topics: Biosimilars
Regions: Global
| Disease-Modifying Antirheumatic Drug (DMARD) Market, by Drug Type (Synthetic (sDMARD), (Conventional synthetic (csDMARDs), (Methotrexate, Sulfasalazine, Leflunomide, Hydroxychloroquine and Gold Salts), Targeted synthetic DMARDs (tsDMARDs), Biological DMAR
Topics: Biosimilars, Arthritis, Autoimmune, Pharmacy & Distribution, Clinical Nutrition, Drug Stores, Rheumatology/Arthritis
Regions: Africa, Asia, Europe, Middle East, North America, Oceania, South America
| Global Interferon Alpha-2a Biosimilar Market Research Report 2022 - Market Size, Current Insights and Development Trends
Topics: Biosimilars, Research & Development
Regions: Global
| CHINA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
Topics: Biosimilars, Diabetes, COVID-19/Coronavirus, Prescription Drugs, Drug Discovery
Regions: China
| Market Study on Biosimilar Insulin: More Than 80% Market Share Accounted for by Insulin Glargine
Topics: Biosimilars, Diabetes
| Global Healthcare Digital Experience Platform Market By Component (Platform (without services), and Services), By Application (Business-to-Consumer (B2C), Business-to-Business (B2B), and Others), By Delivery Mode (Cloud and On-premise), By Regional Outloo
Topics: Biosimilars, B2B, B2C, Hospitals & Clinics, EMR (Electronic Medical Record), Cloud Computing
Regions: Global
| Europe Healthcare Digital Experience Platform Market By Component (Platform (without services), and Services), By Application (Business-to-Consumer (B2C), Business-to-Business (B2B), and Others), By Delivery Mode (Cloud and On-premise), By Country, Opport
Topics: Biosimilars, B2B, B2C, Hospitals & Clinics, EMR (Electronic Medical Record), Cloud Computing
Regions: Europe
| Darbepoetin alfa– Biosimilar Insight, 2022
Topics: Biosimilars
| Epoetin alfa– Biosimilar Insight, 2022
Topics: Biosimilars
| Etanercept– Biosimilar Insight, 2022
Topics: Biosimilars
| Follitropin alfa– Biosimilar Insight, 2022
Topics: Biosimilars
| Pegfilgrastim– Biosimilar Insight, 2022
Topics: Biosimilars
| Teriparatide– Biosimilar Insight, 2022
Topics: Biosimilars
| Global Filgrastim Market By Drug Type (Biosimilar and Biologic), By Indication (Chemotherapy induced Neutropenia, Chronic Neutropenia and Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By Region
Topics: Biosimilars, Biologics, Hospitals & Clinics, Biopharmaceuticals, Drug Stores
Regions: Global
| Europe Filgrastim Market By Drug Type (Biosimilar and Biologic), By Indication (Chemotherapy induced Neutropenia, Chronic Neutropenia and Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By Countr
Topics: Biosimilars, Biologics, Hospitals & Clinics, Biopharmaceuticals, Drug Stores
Regions: Europe
| 2022-2029 Global Herceptin Biosimilar Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)
Topics: Biosimilars
Regions: Global
| Saudi Arabia Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (R
Topics: Biosimilars, Diabetes, Transdermal & Implantable, Diabetes, Infusion Products, Needles, Syringes, IV Access
Regions: Saudi Arabia
| Herceptin Biosimilar Market, by Indication (Breast Cancer, Gastric Cancer, and Others), by Distribution Channel (Hospital, Oncology Centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Sh
Topics: Biosimilars, Cancer Treatment, Hospitals & Clinics, Hematology & Oncology, Oncology/Hematology
Regions: Africa, Asia, Europe, Middle East, North America, Oceania, South America
| India Generic Drugs Market, By Type (Small Molecule Generics v/s Biosimilars), By Mode of Drug Delivery (Oral, Parenteral, Topical, Others), By Form (Tablets, Capsules, Injections, Others), By Source (Contract Manufacturing Organizations v/s In-house), By
Topics: Biosimilars, Hematology & Oncology, Generics Drugs, Manufacturing, Packaging & Detailing, Pharmacy & Distribution, Drug Delivery, Drug Stores, CNS/Neurology
Regions: India
| Biosimilars- Market Insight, Competitive Landscape and Market Forecast- 2027
Topics: Biosimilars
| United States Human Insulin Market, By Product Type (Human Insulin Drugs, Human Insulin Delivery Devices); By Type (Insulin Analogs and Biosimilars, Human Insulin Biologics); By Delivery Devices (Syringes, Pens, Pen Needles); By Application (Type I Diabet
Topics: Biosimilars, Biologics, Diabetes, Diabetes, Needles, Syringes, IV Access, Biopharmaceuticals
Regions: United States
| Middle East and Africa Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered a
Topics: Biosimilars, Antibody Technologies, Autoimmune, COVID-19/Coronavirus, Hematology & Oncology
Regions: Africa, Middle East
| South and Central America Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineere
Topics: Biosimilars, Antibody Technologies, Autoimmune, COVID-19/Coronavirus, Hematology & Oncology
Regions: Central America
| Asia Pacific Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies,
Topics: Biosimilars, Antibody Technologies, Autoimmune, COVID-19/Coronavirus, Oncology/Hematology
Regions: Asia, Oceania
| Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Human Insulin, Human Growth Hormone, Erythropoietin, Interferon, Colony Stimulating Factor, Blood Factors, Fusion Protein, and Other
Topics: Biosimilars, Enzymes, Informatics, Gene Therapy, Antibody Technologies, Biologics, Nanomedicine, Diabetes, Vaccines, Drug Discovery, Biopharmaceuticals
Regions: Asia, Europe, Middle East, North America, Oceania
| Prescriber Opinions on Biosimilars in Immunology
Topics: Biosimilars, Psoriasis, Allergy/Immunology
| 2022-2029 Global Biologics and Biosimilars Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)
Topics: Biosimilars, Biologics, Biopharmaceuticals
Regions: Global
| Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune D
Topics: Biosimilars, Antibody Technologies, Stem Cell, Autoimmune, Hematology & Oncology, CNS/Neurology, Oncology/Hematology
Regions: Asia, Middle East, Oceania
| Europe Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Biologics and Biosimilar), Service (Process Development, Fill and Finish Operation, Analytical and QC Studies, and Packaging), and
Topics: Biosimilars, Biologics, COVID-19/Coronavirus, Biopharmaceuticals
Regions: Europe
| North America Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Biologics and Biosimilar), Service (Process Development, Fill and Finish Operation, Analytical and QC Studies, and Packaging
Topics: Biosimilars, Biologics, COVID-19/Coronavirus, Biopharmaceuticals
Regions: North America
| Asia Pacific Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Biologics and Biosimilar), Service (Process Development, Fill and Finish Operation, Analytical and QC Studies, and Packaging)
Topics: Biosimilars, Biologics, COVID-19/Coronavirus, Biopharmaceuticals
Regions: Asia, Oceania
| Middle East and Africa Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Biologics and Biosimilar), Service (Process Development, Fill and Finish Operation, Analytical and QC Studies, and
Topics: Biosimilars, Biologics, COVID-19/Coronavirus, Biopharmaceuticals
Regions: Africa, Middle East
| Europe Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antib
Topics: Biosimilars, Antibody Technologies, Autoimmune, COVID-19/Coronavirus, Oncology/Hematology
Regions: Europe
| Adalimumab-Biosimilars Insight, 2022
Topics: Biosimilars
| Infliximab-Biosimilars Insight, 2022
Topics: Biosimilars
| Filgrastim - Biosimilar Insight, 2022
Topics: Biosimilars
| Interferon - Biosimilar Insight, 2022
Topics: Biosimilars, Research & Development
| Erythropoietin Stimulating Agents Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Topics: Biosimilars, COVID-19/Coronavirus
| Biosimilar Therapeutic Peptides Global Market Report 2021: COVID-19 Growth And Change To 2030
Topics: Biosimilars, COVID-19/Coronavirus
Regions: Global
| Biosimilar Interleukins Global Market Report 2021: COVID-19 Growth And Change To 2030
Topics: Biosimilars, Research & Development, COVID-19/Coronavirus
Regions: Global
| Biosimilar Hormones Global Market Report 2021: COVID-19 Growth And Change To 2030
Topics: Biosimilars, COVID-19/Coronavirus
Regions: Global
| Global Pegfilgrastim Biosimilars Market - 2021-2028
Topics: Biosimilars
Regions: Global
| United States Generic Drugs Market, By Type (Small Molecule Generics v/s Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Infectious Diseases, Others), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By F
Topics: Biosimilars, Diabetes, Transdermal & Implantable, Hospitals & Clinics, Generics Drugs, Manufacturing, Packaging & Detailing, Drug Delivery, Clinical Nutrition, Drug Stores, Infectious Diseases, Oncology/Hematology
Regions: United States
| Rituximab Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Growth And Change
Topics: Biosimilars, COVID-19/Coronavirus
Regions: Global
| Oncology Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030
Topics: Biosimilars, COVID-19/Coronavirus, Oncology/Hematology
Regions: Global
|
Prev | 1 | 2 | 3 | 4 | 5 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
